Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 3635209, 10 pages
http://dx.doi.org/10.1155/2016/3635209
Research Article

Jin Fu Kang Oral Liquid Inhibits Lymphatic Endothelial Cells Formation and Migration

1Department of Respiratory Medicine, Affiliated Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, China
2State Key Laboratory of Analytical Chemistry for Life Science and Collaborative Innovation Center of Chemistry for Life Sciences, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China
3Tumor Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai 200032, China
4Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai 200437, China

Received 19 March 2016; Accepted 30 June 2016

Academic Editor: Janelle Wheat

Copyright © 2016 Hai-Lang He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Smith, D. Manassaram-Baptiste, D. Brooks et al., “Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 30–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. T. K. Kilvaer, E.-E. Paulsen, S. M. Hald et al., “Lymphangiogenic markers and their impact on nodal metastasis and survival in non-small cell lung cancer—a structured review with meta-analysis,” PLoS ONE, vol. 10, no. 8, Article ID e0132481, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. F. G. Gomes, F. Nedel, A. M. Alves, J. E. Nör, and S. B. C. Tarquinio, “Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms,” Life Sciences, vol. 92, no. 2, pp. 101–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Wang, S. Ma, M. Dong, Y. Yao, K. Liu, and J. Zhou, “Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT,” BMC Pulmonary Medicine, vol. 15, no. 1, article 20, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Sleeman and W. Thiele, “Tumor metastasis and the lymphatic vasculature,” International Journal of Cancer, vol. 125, no. 12, pp. 2747–2756, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Li and Q. Li, “Cancer stem cells, lymphangiogenesis, and lymphatic metastasis,” Cancer Letters, vol. 357, no. 2, pp. 438–447, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Bzowska, R. Mężyk-Kopeć, T. Próchnicki, M. Kulesza, T. Klaus, and J. Bereta, “Antibody-based antiangiogenic and antilymphangiogenic therapies to prevent tumor growth and progression,” Acta Biochimica Polonica, vol. 60, no. 3, pp. 263–275, 2013. View at Google Scholar · View at Scopus
  8. S. A. Stacker, S. P. Williams, T. Karnezis, R. Shayan, S. B. Fox, and M. G. Achen, “Lymphangiogenesis and lymphatic vessel remodelling in cancer,” Nature Reviews Cancer, vol. 14, no. 3, pp. 159–172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Yu, X. Zhang, P. M. Kuzontkoski et al., “Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway,” Cell Communication and Signaling, vol. 12, no. 1, article 25, pp. 1–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-Z. Tan, H.-J. Wang, M.-H. Zhang, Z. Quan, T. Li, and Q.-Z. He, “CD34+VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells,” Journal of Cellular and Molecular Medicine, vol. 18, no. 3, pp. 422–433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Moschetta, Y. Mishima, I. Sahin et al., “Role of endothelial progenitor cells in cancer progression,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1846, no. 1, pp. 26–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Zhuo, L. Jia, N. Song et al., “The CXCL12–CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis,” Clinical Cancer Research, vol. 18, no. 19, pp. 5387–5398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Li, W. Bai, P. Sun, B. Zhou, B. Hu, and J. Ying, “The effect of CXCL12 on endothelial progenitor cells: potential target for angiogenesis in intracerebral hemorrhage,” Journal of Interferon and Cytokine Research, vol. 35, no. 1, pp. 23–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Liu, M. Pan, Y. Li, D. Ye, and Y. Guo, “Clinical study of oral liquid Jin Fu Kang for the treatment of primary non-small cell lung cancer,” Tumor, vol. 21, no. 6, pp. 463–465, 2001. View at Google Scholar
  15. J. Liu, Z. Shi, H. Li et al., “Clinical observation on 271 cases of non-small lung cancer treated with Yifei Kangliu Yin (Jin-Fu-Kang),” Chinese Journal of Integrated Traditional and Western Medicine, vol. 7, no. 4, pp. 247–250, 2001. View at Google Scholar
  16. Z. C. Wang, J. L. Zeng, H. L. Zhang, and J. W. Li, “Jin Fu Kang on tumor growth and metastasis and vascular endothelial growth factor of patients with advanced non-small cell lung cancer,” Practical Journal of Clinical Medicine, vol. 8, no. 4, pp. 148–149, 2011. View at Google Scholar
  17. P. Salven, A. Orpana, and H. Joensuu, “Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor,” Clinical Cancer Research, vol. 5, no. 3, pp. 487–491, 1999. View at Google Scholar · View at Scopus
  18. H.-J. Wang, D. Zhang, Y.-Z. Tan, and T. Li, “Autophagy in endothelial progenitor cells is cytoprotective in hypoxic conditions,” American Journal of Physiology—Cell Physiology, vol. 304, no. 7, pp. C617–C626, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Tawada, S.-I. Hayashi, S. Osada, S. Nakashima, and K. Yoshida, “Human gastric cancer organizes neighboring lymphatic vessels via recruitment of bone marrow-derived lymphatic endothelial progenitor cells,” Journal of Gastroenterology, vol. 47, no. 9, pp. 1057–1060, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Masuda, H. Yasuoka, T. Satoh, Y. Okazaki, Y. Yamaguchi, and M. Kuwana, “Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop,” Arthritis Research and Therapy, vol. 15, article R74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Goldman, T. X. Le, M. Skobe, and M. A. Swartz, “Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin,” Circulation Research, vol. 96, no. 11, pp. 1193–1199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Nishida and H. Satoh, “Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta,” Life Sciences, vol. 72, no. 23, pp. 2659–2667, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Wang, L. Zhu, and Q. Chen, “Primary study on the application of Serum Pharmacology in Chinese traditional medicine,” Colloids and Surfaces B: Biointerfaces, vol. 43, no. 3-4, pp. 194–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Ma, A. Morancho, J. Montaner, and A. Rosell, “Endothelial progenitor cells and revascularization following stroke,” Brain Research, vol. 1623, pp. 150–159, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Qiu, L. Cao, D. Wang, H. Xu, and Z. Liang, “High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer,” Journal of Obstetrics and Gynaecology Research, vol. 39, no. 7, pp. 1268–1275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Furusato, A. Mohamed, M. Uhlén, and J. S. Rhim, “CXCR4 and cancer: review Article,” Pathology International, vol. 60, no. 7, pp. 497–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Karshovska, D. Zagorac, A. Zernecke, C. Weber, and A. Schober, “A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury,” Journal of Thrombosis and Haemostasis, vol. 6, no. 10, pp. 1812–1815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. Chiang and J. Massagué, “Molecular basis of metastasis,” The New England Journal of Medicine, vol. 359, no. 26, pp. 2814–2823, 2008. View at Publisher · View at Google Scholar
  29. T. Li, G.-D. Wang, Y.-Z. Tan, and H.-J. Wang, “Inhibition of lymphangiogenesis of endothelial progenitor cells with VEGFR-3 siRNA delivered with PEI-alginate nanoparticles,” International Journal of Biological Sciences, vol. 10, no. 2, pp. 160–170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Wang and Z. Zou, “Multiple mechanisms of SDF-1 promoting VEGF-induced endothelial differentiation of mesenchymal stem cells,” International Journal of Cardiology, vol. 177, no. 3, pp. 1098–1099, 2014. View at Publisher · View at Google Scholar · View at Scopus